Skip to main content
. 2012 Autumn;11(4):1285–1290.

Table 1.

Amount of immunostaining for BCL-2 protein in skin flap specimens in three different groups.

Groups BCL-2 expression
- +/- + ++ +++ Total
Control 12 (34.3%) 13 (37.1%) 8 (22.9%) 2 (5.7%) 0 (.0%) 35 (100.0%)
Azelaic acid* 7 (20.0%) 10 (28.6%) 12 (34.3%) 5 (14.3%) 1 (2.9%) 35 (100.0%)
Finasteride* 7 (20.0%) 7 (20.0%) 14 (40.0%) 6 (17.1%) 1 (2.9%) 35 (100.0%)

*p < 0.05 compared to the control group